Objective To review and qualitatively synthesize the evidence related to the economic
burden of COVID-19, including healthcare resource utilization and costs. Methods A …

Background We aimed to quantitatively summarise the health economic evaluation
evidence of prevention and control programs addressing COVID-19 globally. Methods We …

As of March 2021, COVID-19 has claimed the lives of more than 2.7 million people
worldwide. Vaccination has started in most countries around the world. In this study, we …

Background Despite the development of safe and effective vaccines, effective treatments for
COVID-19 disease are still urgently needed. Several antiviral drugs have shown to be …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 infection is
the cause of the ongoing global pandemic. Mortality from COVID-19 infection is particularly …

Objectives This study aimed to estimate the cost-effectiveness of remdesivir, the first novel
therapeutic to receive Emergency Use Authorization for the treatment of hospitalized …

Objectives As healthcare systems continue to respond to the COVID-19 pandemic, cost-
effectiveness evidence will be needed to identify which tests and treatments for COVID-19 …

Background The COVID-19 outbreak was defined as a pandemic on 11 March 2020 by the
World Health Organization. After that, COVID-19 has enormously influenced health systems …

OBJECTIVES Many countries have authorized the emergency use of oral antiviral agents for
patients with mild-to-moderate cases of coronavirus disease 2019 (COVID-19). We …

Introduction This study aims to evaluate the cost-effectiveness of remdesivir compared to
other existing therapies (SoC) in Turkey to treat COVID-19 patients hospitalized with< 94 …